Cargando…

A Prognostic Score for the Prediction of Local Treatment Failure in Plaque Brachytherapy of Uveal Melanoma

PURPOSE: To develop a prognostic score that correlates to a low, medium, and high incidence of treatment failure after plaque brachytherapy of uveal melanoma (UM). METHODS AND MATERIALS: All patients who have received plaque brachytherapy for posterior UM at St. Erik Eye Hospital in Stockholm, Swede...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kal Omar, Ruba, Hagström, Anna, Dahlander, Simon, Carlsson Tedgren, Åsa, Stålhammar, Gustav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991540/ https://www.ncbi.nlm.nih.gov/pubmed/36896210 http://dx.doi.org/10.1016/j.adro.2022.101152

Ejemplares similares

Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study
por: Kal Omar, Ruba, et al.
Publicado: (2023)

The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature
por: Hagström, Anna, et al.
Publicado: (2022)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020)

Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016)

The prognostic implication of visual acuity at the time of uveal melanoma diagnosis
por: Asplund, Elin, et al.
Publicado: (2022)

Sex‐based differences in early and late uveal melanoma‐related mortality
por: Stålhammar, Gustav
Publicado: (2022)

Intratumor Heterogeneity in Uveal Melanoma BAP-1 Expression
por: Stålhammar, Gustav, et al.
Publicado: (2021)

Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
por: Fang, Rui, et al.
Publicado: (2021)

(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020)

Staged Eye-Plaque Brachytherapy: A Novel Approach for Large Uveal Melanoma
por: Chevli, Neil, et al.
Publicado: (2021)

Long-term relative survival in uveal melanoma: a systematic review and meta-analysis
por: Stålhammar, Gustav, et al.
Publicado: (2022)

Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma
por: Sabazade, Shiva, et al.
Publicado: (2021)

Intra-operative ocular ultrasonography of iodine-125 brachytherapy plaques in patients with uveal melanoma
por: Ces, Antonio Piñeiro, et al.
Publicado: (2021)

Prognosis Prediction of Uveal Melanoma After Plaque Brachytherapy Based on Ultrasound With Machine Learning
por: Luo, Jingting, et al.
Publicado: (2022)

An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage
por: Morén, Björn, et al.
Publicado: (2019)

Digital morphometry and cluster analysis identifies four types of melanocyte during uveal melanoma progression
por: Stålhammar, Gustav, et al.
Publicado: (2023)

The prognostic implication of latitude in uveal melanoma: a nationwide observational cohort study of all patients born in Sweden between 1947 and 1989
por: Stålhammar, Gustav, et al.
Publicado: (2022)

Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma
por: Tagliaferri, Luca, et al.
Publicado: (2017)

An audit of high dose-rate prostate brachytherapy treatment planning at six Swedish clinics
por: Dohlmar, Frida, et al.
Publicado: (2021)

Estimation of the timing of BAP1 mutation in uveal melanoma progression
por: Uner, Ogul E., et al.
Publicado: (2021)

Editorial: Uveal melanoma: from lab bench to clinic – new therapeutic advances
por: D'Amico, Agata Grazia, et al.
Publicado: (2023)

Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas
por: Tarmann, Lisa, et al.
Publicado: (2017)

Cherenkov Luminescence Imaging for Assessment of Radioactive Plaque Position in Brachytherapy of Uveal Melanoma: An In Vivo Feasibility Study
por: Krohn, Jørgen, et al.
Publicado: (2020)

Reduced blood flow by laser speckle flowgraphy after (125)I-plaque brachytherapy for uveal melanoma
por: Tamplin, Michelle R., et al.
Publicado: (2022)

Digital Image Analysis of BAP-1 Accurately Predicts Uveal Melanoma Metastasis
por: Stålhammar, Gustav, et al.
Publicado: (2019)

Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)

Author Correction: Estimation of the timing of BAP1 mutation in uveal melanoma progression
por: Uner, Ogul E., et al.
Publicado: (2021)

Outcomes and Control Rates for I-125 Plaque Brachytherapy for Uveal Melanoma: A Community-Based Institutional Experience
por: Wagner, Aaron, et al.
Publicado: (2014)

Preliminary Results of Uveal Melanoma Treated With Iodine-125 Plaques: Analysis of Disease Control and Visual Outcomes With 63 Gy to the Target Volume
por: Kheir, Wajiha J., et al.
Publicado: (2022)

(103)Pd versus (125)I ophthalmic plaque brachytherapy: preoperative comparative radiation dosimetry for 319 uveal melanomas
por: Finger, Paul T., et al.
Publicado: (2014)

Temporal Relationship Between Visual Field, Retinal and Microvascular Pathology Following (125)I-Plaque Brachytherapy for Uveal Melanoma
por: Tamplin, Michelle R., et al.
Publicado: (2021)

Multiorgan Involvement of Dormant Uveal Melanoma Micrometastases in Postmortem Tissue From Patients Without Coexisting Macrometastases
por: Gill, Viktor T, et al.
Publicado: (2023)

Radiological and clinical findings in uveal melanoma treated by plaque interventional radiotherapy (brachytherapy): Visual atlas and literature review on response assessment
por: Fionda, Bruno, et al.
Publicado: (2022)

Longitudinal optical coherence tomography angiography (OCT-A) in a patient with radiation retinopathy following plaque brachytherapy for uveal melanoma
por: Binkley, Elaine M., et al.
Publicado: (2022)

A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival
por: Herrspiegel, Christina, et al.
Publicado: (2023)

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
por: Brewington, Beatrice Y, et al.
Publicado: (2018)

Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022)

Clinical Outcomes after Surgical Resection Combined with Brachytherapy for Uveal Melanomas
por: Relimpio-López, Isabel, et al.
Publicado: (2022)

Inter-Observer Variability in MR-Based Target Volume Delineation of Uveal Melanoma
por: Jaarsma-Coes, Myriam G., et al.
Publicado: (2022)

Trends in Uveal Melanoma Presentation and Survival During Five Decades: A Nationwide Survey of 3898 Swedish Patients
por: Gill, Viktor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ou1nlkflso9v08sm7cji21dt7v